We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$11.6B
AUM Growth
+$227M
Cap. Flow
-$9.15M
Cap. Flow %
-0.08%
Top 10 Hldgs %
29.6%
Holding
866
New
62
Increased
271
Reduced
428
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 25.25%
2 Financials 9.37%
3 Communication Services 8.09%
4 Consumer Discretionary 7.76%
5 Healthcare 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
626
Encompass Health
EHC
$12.2B
$922K 0.01%
8,688
-1,430
-14% -$166K
RMBS icon
627
Rambus
RMBS
$11B
$921K 0.01%
+10,020
New +$986K
MKSI icon
628
MKS Inc
MKSI
$21.3B
$917K 0.01%
5,738
-584
-9% -$86.6K
JEF icon
629
Jefferies Financial Group
JEF
$12.7B
$917K 0.01%
+14,794
New +$848K
DVA icon
630
DaVita
DVA
$11.5B
$910K 0.01%
8,008
-941
-11% -$114K
MRVL icon
631
Marvell Technology
MRVL
$205B
$909K 0.01%
10,694
-28
-0.3% -$2.45K
AFG icon
632
American Financial Group
AFG
$12B
$908K 0.01%
+6,644
New +$912K
DCI icon
633
Donaldson
DCI
$11.1B
$908K 0.01%
10,238
-1,644
-14% -$143K
LSCC icon
634
Lattice Semiconductor
LSCC
$18.4B
$895K 0.01%
12,165
-1,671
-12% -$119K
EXEL icon
635
Exelixis
EXEL
$12.6B
$892K 0.01%
20,342
-4,076
-17% -$169K
WTRG icon
636
Essential Utilities
WTRG
$11.5B
$882K 0.01%
22,985
-3,998
-15% -$157K
AIT icon
637
Applied Industrial Technologies
AIT
$13.1B
$868K 0.01%
3,382
-443
-12% -$113K
SPXC icon
638
SPX Corp
SPXC
$10.9B
$865K 0.01%
4,326
-235
-5% -$48K
ENSG icon
639
The Ensign Group
ENSG
$10.6B
$863K 0.01%
4,954
-685
-12% -$123K
BWA icon
640
BorgWarner
BWA
$14B
$857K 0.01%
19,029
-3,183
-14% -$139K
WMS icon
641
Advanced Drainage Systems
WMS
$11.2B
$854K 0.01%
5,895
-876
-13% -$127K
HLI icon
642
Houlihan Lokey
HLI
$8.7B
$850K 0.01%
+4,881
New +$896K
DY icon
643
Dycom Industries
DY
$12.4B
$849K 0.01%
2,512
-332
-12% -$105K
SSB icon
644
SouthState Bank Corp
SSB
$10.8B
$834K 0.01%
+8,857
New +$820K
OC icon
645
Owens Corning
OC
$12.4B
$830K 0.01%
7,415
-1,386
-16% -$163K
FLS icon
646
Flowserve
FLS
$10.2B
$827K 0.01%
11,918
-1,335
-10% -$85.8K
BBIO icon
647
BridgeBio Pharma
BBIO
$16B
$823K 0.01%
10,761
-1,521
-12% -$99.8K
ARGX icon
648
argenx
ARGX
$54B
$822K 0.01%
977
-98
-9% -$83.9K
WTFC icon
649
Wintrust Financial
WTFC
$11B
$822K 0.01%
+5,876
New +$781K
ARMK icon
650
Aramark
ARMK
$16.2B
$819K 0.01%
22,211
-3,070
-12% -$117K

Similar funds

New York Life Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, New York Life Investment Management held 866 positions worth $11.6B, up 2% from $11.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

New York Life Investment Management's Q4 2025 filing shows 62 new, 271 increased, 428 reduced and 100 closed positions. Its largest new stake was NYLI MacKay Muni Allocation ETF: 995,000 shares worth $24.9M. The largest sale was IQ Candriam US Large Cap Equity ETF, an estimated $45.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Communication Services.

  • New York Life Investment Management's largest Q4 2025 buy was NYLI MacKay Muni Allocation ETF: 995,000 shares worth $24.9M.
  • New York Life Investment Management added most to Vanguard Short-Term Treasury ETF in Q4 2025, an estimated $113M increase.
  • New York Life Investment Management's biggest Q4 2025 reduction was IQ Candriam US Large Cap Equity ETF, cutting an estimated $45.6M.
  • New York Life Investment Management fully exited Linde in Q4 2025, selling an estimated $32.5M.
  • New York Life Investment Management's ten largest holdings make up 30% of its $11.6B portfolio in Q4 2025.
  • New York Life Investment Management opened 62 new positions and closed 100 in Q4 2025.
  • New York Life Investment Management's portfolio value rose 2% quarter-over-quarter to $11.6B.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.